J Child Orthop. 2007 Sep;1(3):195-203. doi: 10.1007/s11832-007-0042-4. Epub 2007 Sep 01.
Soft-tissue sarcomas of the extremities in patients of pediatric age.
Journal of children's orthopaedics
Michela Casanova, Cristina Meazza, Alessandro Gronchi, Marco Fiore, Elena Zaffignani, Marta Podda, Paola Collini, Lorenza Gandola, Andrea Ferrari
Affiliations
Affiliations
- Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian, 1, 20133, Milan MI, Italy.
PMID: 19308495
PMCID: PMC2656726 DOI: 10.1007/s11832-007-0042-4
Abstract
PURPOSE: The extremity site is a peculiar location for soft-tissue sarcomas (STS) of children and adolescents. Here we report the experience of the Pediatric Oncology Unit of the Istituto Nazionale Tumori of Milan, Italy, concerning 204 patients with STS of the limbs treated between 1977 and 2006.
METHODS: The study series included 52 patients with rhabdomyosarcoma (RMS)(65% of which were of the alveolar subtype), nine with extraosseous Ewing sarcoma and 143 with non-rhabdomyosarcoma soft-tissue sarcomas (NRSTS), 38% of which were synovial sarcoma. Patients were treated with a multimodality approach including surgery, chemotherapy, and radiotherapy.
RESULTS: For the RMS patients, the 5-year event-free survival (EFS) rate was 37.1%, with distant metastases being the main cause of treatment failure. The outcome was particularly poor for patients with large invasive tumors, hand/foot involvement and/or nodal or distant metastases, and for patients who were not given radiotherapy. For the extraosseous Ewing sarcoma cases, 5-year EFS was 74%. For the NRSTS cases, the 5-year EFS was 72.6%: tumor size and local invasiveness, tumor grade, malignant peripheral nerve sheath tumor (MPNST) histology, and distant metastases were the main prognostic factors.
DISCUSSION: While the limbs are the most common sites of NRSTS and are often characterized by a more favorable prognosis than for axial tumors, the clinical features of extremity RMS often differ from those of RMS of other sites, with a higher incidence of unfavorable prognostic factors (e.g., alveolar subtype) and consequently unsatisfactory treatment results. The treatment of these patients is complex and necessarily multidisciplinary, and it demands not only adequate experience of treating children and adolescents in clinical trials, but also particular skills in the field of orthopedic surgery.
References
- J Clin Oncol. 2005 Jun 20;23(18):4021-30 - PubMed
- J Pediatr Surg. 1997 May;32(5):698-702 - PubMed
- J Pediatr Surg. 2000 Jun;35(6):961-4 - PubMed
- Cancer. 1990 Dec 15;66(12):2482-91 - PubMed
- Expert Rev Anticancer Ther. 2005 Apr;5(2):307-18 - PubMed
- Med Pediatr Oncol. 1990;18(6):466-71 - PubMed
- J Pediatr Surg. 1990 Feb;25(2):238-43; discussion 243-4 - PubMed
- Pediatr Blood Cancer. 2004 Apr;42(4):295-310 - PubMed
- J Clin Oncol. 2005 Nov 20;23(33):8422-30 - PubMed
- Semin Surg Oncol. 1993 Nov-Dec;9(6):510-9 - PubMed
- J Pediatr Surg. 1989 Jan;24(1):5-10 - PubMed
- Cancer. 2006 Feb 1;106(3):708-17 - PubMed
- Cancer. 1988 Jan 15;61(2):209-20 - PubMed
- Pediatr Dev Pathol. 2004 Jul-Aug;7(4):361-9 - PubMed
- Pediatr Surg Int. 2003 Aug;19(6):453-6 - PubMed
- J Pediatr Hematol Oncol. 2003 Nov;25(11):905-9 - PubMed
- J Pediatr Surg. 1997 Aug;32(8):1181-4 - PubMed
- Cancer. 2005 Nov 1;104(9):2006-12 - PubMed
- J Pediatr Surg. 2002 Oct;37(10):1424-9 - PubMed
- J Pediatr Surg. 1996 Jan;31(1):191-6 - PubMed
- World J Surg. 1988 Oct;12(5):676-84 - PubMed
- Med Pediatr Oncol. 2003 Dec;41(6):584-7 - PubMed
- Int J Cancer. 1984 Jan 15;33(1):37-42 - PubMed
- Eur J Surg Oncol. 2000 Nov;26(7):669-78 - PubMed
- J Pediatr Surg. 2000 Feb;35(2):317-21 - PubMed
- Clin Orthop Relat Res. 2004 Sep;(426):129-34 - PubMed
Publication Types